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The receptor of hepatocyte growth factor (HGF), c-met induces different physiological responses in several cell types. Little is known
about the role of HGF in exocrine pancreas. However, abnormal HGF signaling has been strongly implicated in pancreatic tumorigenesis and
association of HGF with pancreatitis has been demonstrated. We have studied the presence of c-met and activation of their intracellular
pathways associated in rat pancreatic acini in comparison with cholecystokinin (CCK) and epidermal growth factor (EGF). C-met expression
in rat exocrine pancreas was identified by immunohistochemistry and immunoprecipitation followed by Western analysis. Tyrosine
phosphorylation of c-met is strongly stimulated as well as kinase pathways leading to ERK1/2 cascade. HGF, but not CCK or EGF,
selectively caused a consistent increase in the amount of p85 regulatory subunit of PI3-K present in anti-phosphotyrosine
immunoprecipitates. Downstream of PI3-K, HGF increased Ser473 phosphorylation of Akt selectively, as CCK or EGF did not affect it.
HGF selectively stimulated tyrosine phosphorylation of phosphatase PTP1D. HGF failed to promote the well-known CCK effects in
pancreatic acini such as amylase secretion and intracellular calcium mobilization. Although HGF shares activation of ERK1/2 with CCK, we
demonstrate that it promotes the selective activation of intracellular pathways not regulated by CCK or EGF. Our results suggest that HGF is
an in vivo stimulus of pancreatic acini and provide novel insight into the transduction pathways and effects of c-met/HGF in normal
pancreatic acinar cells.
D 2003 Elsevier B.V. All rights reserved.Keywords: Pancreatic acini; Hepatocyte growth factor; PI3-Kinase; ERK1/2; PTP1D; Amylase secretion
1. Introduction autophosphorylation of specific tyrosine residues within theHepatocyte growth factor (HGF) was identified indepen-
dently as both a growth factor for hepatocytes and a
fibroblast-derived cell motility factor, scatter factor (SF). It
binds to its receptor tyrosine kinase (c-met), which was
discovered as an activated oncogene [1]. In vivo, the
expression of c-met is predominately found in cells of
epithelial origin while HGF/SF expression is usually re-
stricted to fibroblasts and stromal cells in the surrounding
mesenchyme [2]. Activation of signal transduction path-
ways in response to HGF stimulation is mediated in part by0167-4889/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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E-mail address: ljgarcia@unex.es (L.J. Garcia-Marin).intracellular region of c-met. Phosphorylation of Tyr1234 and
Tyr1235 located within the activation loop of the tyrosine
kinase domain activates the intrinsic kinase activity of the
receptor, while phosphorylation of Tyr1349 and Tyr1356 in the
C-terminus activates a multisubstrate docking site conserved
among Met family members [2]. This multisubstrate dock-
ing site mediates the binding of several adapter proteins
such as Grb2, Shc, Crk/CRKL and Gab1 which in turn
recruit several signal transducing proteins to form signaling
complexes [2].
HGF/SF induces different cellular responses depending
on the cellular context: proliferation, cell dissociation and
motility, cell movement through the extracellular matrix,
angiogenesis, tissue regeneration, cell differentiation and
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involved in many aspects of embryogenesis, abnormal
HGF signaling has been strongly implicated in tumorigen-
esis, particularly in the development of invasive and meta-
static phenotypes [2]. Recently, c-met mutations have been
identified in patients with several types of carcinoma [2] and
cell lines generated that express mutated Met receptors that
mimic those found in human cancers from tumors that are
both highly invasive and metastatic [3,4]. Additionally,
several groups have reported that c-met and/or HGF expres-
sion is increased in a variety of human tumors (reviewed by
Jeffers et al. [5]).
Although the physiological role of HGF has been well
studied in epithelial cell types, to date, little is known about
the biological responses evoked by HGF in pancreas.
Previous data in the rat demonstrated that the period of
maximal expression of HGF and its receptor matches the
period of rapid proliferation of the rat gland, including
endocrine and exocrine pancreas [6]. It has been proposed
that HGF and c-met could be implicated in normal rat
pancreas development and maturation [6]. Additionally Vila
et al. [7,8] reported HGF as a potent mitogen for normal
human exocrine pancreatic cells in vitro, and suggested that
HGF and c-met may play a role in growth regulation of
normal human pancreas.
It has been demonstrated that a concomitant HGF [9]
and c-met [9–12] overexpression in human pancreatic
cancers, which suggests that there is excessive activation
of c-met-dependent signaling pathways, may have an im-
portant pathogenic role during the early stages of neoplastic
promotion and also contribute to pancreatic cancer growth
in vivo.
On the other hand, HGF and c-met mRNA expression
were dramatically increased during chronic [13] and ceru-
lein-induced acute pancreatitis [14] in the rat, which sug-
gests an essential role of this growth factor in the
morphological changes during the development of these
diseases of the exocrine pancreas. The regenerative process
after acute inflammation of the pancreas also appears to
involve HGF action [15].
It is proposed that c-met likely activates similar signal
transduction pathways to promote invasive growth during
both embryonic development and tumor progression, and
additional effects during and after pancreatitis. Therefore,
insights into the signaling requirements to promote its
physiological role in normal pancreatic tissue will likely
be applicable to its associated events in both tumorigenesis
and pancreatitis. Thus the aim of this study was to analyze
intracellular signaling pathways activated by HGF and its
receptor c-met in rat primary pancreatic acini. C-met ex-
pression in rat pancreatic acini was studied and HGF-
induced signal transduction cascades were compared with
those activated by another growth factor, epidermal growth
factor (EGF), and by the main gastrointestinal hormone that
regulates pancreatic acinar cell function, cholecystokinin
(CCK).2. Materials and methods
2.1. Materials
Male Wistar rats (150–200 g) were obtained from the
animal farm, Faculty of Veterinary, UEX, Spain; purified
collagenase (CLSPA) from Worthington Biochemicals,
Freehold, NJ; COOH-terminal octapeptide of CCK-8 and
recombinant Hepatocyte Growth Factor (human) from
Bachem AG, Bubendorf, Switzerland; EGF from Calbio-
chem, La Jolla, CA, anti-phosphotyrosine monoclonal
antibody, (PY20) and anti-PTP1D monoclonal antibody
from Transduction Laboratories, Lexington, KY; anti-
phosphotyrosine monoclonal antibody (4G10) and anti-
rat PI3-Kinase antibody (rabbit whole antiserum) from
Upstate Biotechnology Inc., Lake Placid, NY; anti-
phospho-Akt polyclonal antibody, anti-Akt polyclonal
antibody, anti-phospho ERK1/2 polyclonal antibody
and anti-ERK1/2 polyclonal antibody from Cell Signal-
ing Technology, Beverly, MA; anti-c-met polyclonal
antibody from Santa Cruz Biotechnology, Inc., Santa
Cruz, CA; Tris/Glycine/SDS buffer (concentrated 10)
and Tris/Glycine buffer (concentrated 10) from BIO-
RAD, Richmond, CA; Hyperfilm ECL from Amersham,
Arlington Heights, IL; enhanced chemiluminescence
detection reagents and anti-mouse IgG-horseradish per-
oxidase conjugate from Pierce, Rockford, IL, and nitro-
cellulose membranes from Schleicher & Schuell, Keene,
NH.
2.2. Methods
2.2.1. Rat pancreatic acini isolation
Dispersed rat pancreatic acini were prepared according to
modifications [16] of the procedure previously published
[17]. Unless otherwise stated, the standard incubation solu-
tion contained (mM): HEPES (25.5) [pH 7.4]; NaCl (98);
KCl (6); NaH2PO4 (2.5); sodium pyruvate (5); sodium
fumarate (5); sodium glutamate (5); glucose (11.5); CaCl2
(0.5); MgCl2 (1); glutamine (2); albumin 1% (w/v); trypsin
inhibitor 1% (w/v); vitamin mixture 1% (v/v); and amino
acid mixture 1% (w/v) performed with 100% O2 as the gas
phase.
2.2.2. Immunoprecipitation
Pancreatic acini isolated from one rat were preincubated
with standard incubation solution for 3 h at 37 jC. Acini
were then incubated with agonists at concentrations and
times indicated, washed with phosphate buffered saline
(PBS) with 0.2 mM Na3VO4, and sonicated for 5 s at 4
jC in lysis buffer. Lysates were centrifuged at 10,000 g
for 15 min. Protein concentration in supernatant was
standardized to 500 Ag/ml and 1 ml was incubated
overnight at 4 jC with anti-phosphotyrosine (PY20)
mAb (4 Ag) or anti-c-Met pAb (4 Ag), bridging antibody
(4 Ag) and 25 Al of protein A-agarose. Immunoprecipitates
Fig. 1. C-met immunohistochemistry. (a) Panoramic overview showing a
general and intense anti-c-met immunoreaction ( 125). (b) The stronger
anti-c-met immunoreactivity is located in the cell periphery ( 500). (c)
Control section, the primary antibody was used after blocking with the
antigen used as immunogen ( 60).
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polyacrylamide gel electrophoresis (PAGE) and Western
blotting.
2.3. Western blotting
Proteins in total cellular lysates, immunoprecipitates or
pancreatic homogenates were resolved by SDS-PAGE and
transferred to nitrocellulose membranes. Western blotting
was realized as previously described [18,19] using the
following primary antibodies concentrations: 0.2 Ag/ml
anti-c-met pAb or 0.25 Ag/ml anti-phosphotyrosine mAb
(4G10) or 1:1000 anti-phospho-ERK1/2 pAb or 1:500 anti-
ERK1/2 pAb or 1:1000 anti-phospho-Akt pAb or 1:500
anti-Akt pAb or 1:750 anti-rat-PI3-Kinase whole antiserum
or 0.25 Ag/ml anti-PTP1D pAb.
2.3.1. Immunohistochemistry
Fragments of surgically resected rat pancreas were fixed
in 3% paraformaldehyde in PBS (0.1 M, 7.4 pH) for 15
min and in 70 jC ethanol for 15 min, dehydrated in
ethanol and paraffin embedded. Transverse sections were
cut at 9 Am. Immunohistochemistry was carried out using
the peroxidase–antiperoxidase (PAP) method. Briefly, after
treatment with normal goat serum (1:30 diluted), sections
were incubated with anti-c-met primary antibody (1:250).
The goat anti-rabbit PAP-conjugated secondary antibody
was diluted 1:500 and a solution of diaminobenzidine
(DAB) (0.025% DAB and 0.015% H2O2) was used as
chromogen to visualize peroxidase. Finally, sections were
washed, dehydrated in ethanol and mounted in Depex.
Control procedures included a second-level control and the
absorption control. In the first procedure, the primary
antibody was omitted in some sections. In the second
control procedure, sections were immunostained using
the primary antibody previously incubated for 2 h with
the antigen used as immunogen (1:5 antibody/antigen).
These control sections showed no immunoreactive product
(Fig. 1c).
2.3.2. Intracellular Ca2+measurements
After isolation, pancreatic acini were resuspended in
Na-HEPES medium containing: NaCl 130 mmol/l, KCl 5
mmol/l, HEPES 20 mmol/l, KH2PO4 1.2 mmol/l, D-glu-
cose 10 mmol/l, CaCl2 1 mmol/l, trypsin inhibitor 0.1 mg/
ml, and loaded with 2 AM fura 2/AM for 30–40 min at 25
jC. After loading, the cells were washed and used within
the next 3 h. For measurements of [Ca2 +]i, 2 ml of acinar
cells were placed in quartz cuvettes in a spectrofluoropho-
tometer RF-5001PC (Shimadzu Europe GmbH, Duisburg,
Denmark). Fluorescence was measured at 500 nm after
excitation at 340 nm (F340) and 380 nm (F380). Stimuli
were added directly to cell suspensions in the cuvette to
the final concentration indicated. At the end of each
experiment, maximum and minimum fluorescence ratio
values were obtained by the respective addition of TritonX-100 (20 Al of a 10% stock solution) and EGTA (150
Al of a 0.5 mol/l stock solution in Tris–HCl 3 M, pH 8.9).
Values for [Ca2 +]i were calculated, after subtraction of
background auto fluorescence, as described previously
[20].
2.3.3. Amylase release
Amylase release was measured using the procedure
published previously [17,21]. Briefly, acini from one
pancreas were suspended in 100 ml of standard incubation
solution. Acini were incubated with agonists at 37 jC for
30 min. Amylase activity was determined using the
Phadebas reagent (Pharmacia) and was expressed as the
percentage of cellular amylase released into the extracel-
lular medium during incubation.
Fig. 2. Identification of c-met in pancreatic acini. Rat pancreatic acini were treated for 5 min with no addition or with 1 nM HGF and then lysed. Whole cell
lysates from untreated acini were immunoprecipitated (IP) and analyzed by Western blotting (WB) using anti c-met (c-met) antibody (left panel). Whole cell
lysates were immunoprecipitated with anti c-met antibody (middle panel) or anti-phosphotyrosine PY20 (right panel). Cell lysates or immunoprecipitates were
analyzed by Western blotting using either anti-phosphotyrosine antibody 4G10 (middle panel) or anti c-met antibody (right panel). The positions of the
ntative of three independent experiments.
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All data provided are reported as meanF standard error
(S.E.).
molecular markers are indicated on the left side. Results shown are represe3. Results
3.1. Identification of c-met in rat pancreatic acini and its
regulation by HGF stimulation
The immunohistochemical study showed an overall and
clear anti-c-met immunoreactivity in the pancreatic tissue
(Fig. 1a). No clear differences on anti-c-met immunoreac-
tivity were observed when compared both fixative proce-
dures. Acinar cells and islet cells showed anti c-metFig. 3. c-Met is tyrosine phosphorylated following HGF stimulation. Rat pancreatic
and then lysed. Whole cell lysates were immunoprecipitated with anti-phosphotyro
c-met antibody. In panel A, the upper panel shows a representative experiment
meanF S.E. of four independent experiments. Quantification of bands was per
experiment where acini were incubated with different concentrations of HGF, whic
c-met tyrosine phosphorylation: acini were incubated with HGF (1 nM, 5 min), o
representative of four independent experiments.immunoreactivity, although the endocrine islet cells ap-
peared a little less immunostained. The epithelial cells of
interlobular ducts also showed anti-c-met immunoreactivity.
The stronger immunoreactivity was localized in the periph-
ery of acinar cells (Fig. 1b); on the contrary, the nucleus
always appeared as an immunonegative structure (Fig. 1a).
To study the expression of c-met in rat pancreatic acini,
immunoprecipitates from the whole acinar lysates using a c-
met antibody were separated in SDS-PAGE and analyzed by
Western blotting using anti-c-met-specific antibody. Results
shown in Fig. 2 (left panel) demonstrated a unique and
specific band at the suitable molecular weight of the c-met
(145 kDa).
To investigate whether c-met was regulated by tyrosine
phosphorylation after HGF stimulation, we first immuno-acini were treated with vehicle or HGF at concentration and time indicated,
sine PY20 antibody and Western blotting analysis was performed using anti
with HGF at the indicated times. Values shown in the bottom graph are
formed by scanning densitometry. Panel B, results are shown from one
h is representative of three others. Panel C, effect of HGF, CCK-8 or EGF on
r CCK (10 nM, 2.5 min) or EGF (10 nM, 1 min) and the results shown are
Fig. 4. HGF does not mobilize intracellular calcium nor promote amylase
secretion in pancreatic acinar cells. Upper panel: acinar cells were loaded
with Fura 2-AM and then stimulated with HGF (0.66 nM). Intracellular
calcium was measured as described in Methods. Cholecystokinin (10 nM)
was used as a positive control. Results shown are representative of four
independent experiments. Lower panel: rat pancreatic acini were treated
with vehicle, CCK-8 or HGF at the concentrations indicated and then
amylase released into the incubation media was measured as described in
Methods. Results shown are the meanF S.E. of three independent
experiments, each sample was performed in duplicate.
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analyzed by Western blotting using a specific anti-phospho-
tyrosine antibody 4G10 (Fig. 2, middle panel). In unstimu-
lated conditions, there is no visible tyrosine phosphorylation
of the c-met in rat pancreatic acini (lane 1), while 1 nM HGF
treatment promoted a marked increase in tyrosine phosphor-
ylation of its own receptor (lane 2). Similar results were
observed when antibodies are used in the reverse order, we
first immunoprecipitated phosphotyrosine-containing pro-
teins from the acinar lysates using PY20 antibody. Immu-
nopurified proteins were subsequently analyzed by Western
blotting using the specific anti-c-met antibody (Fig. 2, right
panel).
3.2. Tyrosine phosphorylation of c-met induced by HGF is
time- and concentration-dependent
In rat pancreatic acini c-met tyrosine phosphorylation
induced by 1 nM HGF was time-dependent (Fig. 3, panel A)
with an increase detected within 1 min and a maximum
reached within 5 min. The extent of phosphorylation
remained elevated for at least until 30 min after the addition
of HGF. The tyrosine phosphorylation state of the receptor
induced by HGF in pancreatic acini was dose-dependent
(Fig. 3, panel B) with a half-maximal effect at about 0.1 nM.
A detectable increase was seen after incubation with 0.03
nM HGF for 5 min (lane 2) and the maximum effect was
observed at 1 nM HGF (lane 7).
Tyrosine phosphorylation of c-met specifically occurred
as a consequence of the addition of its ligand HGF, because
with other well-known stimuli of pancreatic acinar cells
such as CCK or EGF there was no appreciable effect (Fig. 3,
panel C).
3.3. HGF and intracellular calcium mobilization in rat
pancreatic acini
As a secretor epithelial type, pancreatic acinar cells
possess a physiological function that is critically dependent
on the intracellular calcium concentration [22]. We inves-
tigated whether HGF treatment affects this intracellular
messenger by determining the intracellular calcium con-
centration [19,20]. As seen in Fig. 4, HGF stimulation of
pancreatic acini did not cause any effect on the intracel-
lular calcium levels, whereas CCK mobilized intracellular
calcium in the same cells under the same experimental
conditions.
3.4. HGF does not promote enzyme secretion in pancreatic
acinar cells
To investigate whether c-met activation in pancreatic
acinar cells is involved in enzyme secretion, we studied its
effects on amylase release. Pancreatic acinar cells responded
to CCK stimulation by releasing amylase into the medium in
a concentration-dependent manner, whereas HGF did nothave any effect on the levels of amylase released at any
concentration tested (Fig. 4).
3.5. Activation of intracellular pathways by HGF stimula-
tion in rat pancreatic acinar cells
HGF stimulation promoted the rapid phosphorylation of
the p44 and p42 ERK1/2 in pancreatic acini (Fig. 5, panel
A). Phosphorylation of ERK1/2 was time- and concentra-
tion-dependent after HGF stimulation (Fig. 5, panels A and
B). A detectable increase was observed at 1 min, whereas
the maximal phosphorylation degree was obtained after 2.5
min incubation with HGF (Fig. 5, panel A). A visible effect
was observed with 0.06 nM HGF and the maximal phos-
phorylation was achieved with 0.3–0.6 nM HGF (Fig. 5,
panel B). The extent of phosphorylation of ERK1/2 pro-
moted by HGF was similar to that obtained with a maxi-
mally effective concentration of CCK in these cells and
higher than that seen with EGF (Fig. 5, panel A).
Fig. 5. HGF stimulation leads to ERK1/2 activation in a time- and concentration-dependent manner. Rat pancreatic acini were treated for indicated time with no
addition or with indicated HGF concentration and lysed. Cell lysates (10 Ag) were analyzed by SDS-PAGE and Western blotting using anti-phospho-ERK1/2 or
anti-ERK1/2-specific antibodies. Panel A, time course of HGF stimulation of ERK1/2 activation. Upper panel: results from a representative experiment with
HGF (1 nM) at the indicated times. Lower panel: quantification of bands was performed by scanning densitometry. Values shown at the bottom graph are
meanF S.E. of four independent experiments. Panel B, HGF concentration-dependence of ERK1/2 activation. Acini were incubated 2.5 min with the indicated
HGF concentrations and the results shown are representative of three independent experiments. Panel C, effect of HGF, CCK-8 or EGF on ERK1/2 activation.
Acini were incubated with HGF (1 nM, 2.5 min), or CCK (10 nM, 2.5 min) or EGF (10 nM, 1 min) and the results shown are representative of three
independent experiments.
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rapid and marked increase in the amount of p85 regulatory
subunit of the PI3-K present in anti-phosphotyrosine immu-
noprecipitates (Fig. 6). The level of p85 subunit associated
with the phosphotyrosine immunoprecipitates was depen-
dent of the incubation time, being detectable at 1 min (4-fold
increase) and remains elevated above control levels (3-foldFig. 6. HGF stimulation increases the amount of p85 subunit (PI3K) in anti-p
indicated times with no addition or with indicated HGF concentration and lysed
Resulting immunocomplexes were analyzed by Western blotting with anti-p85 s
phosphorylated proteins. The upper panel is a representative experiment showing a
by scanning densitometry. Values shown at the bottom graph are meanF S.E. of
p85 association. Acini were incubated 2.5 min with indicated HGF concentrations
Panel C, ability of HGF, CCK-8 or EGF to cause p85 association. Acini were incub
1 min) and the results shown are representative of four independent experiments.increase) until at least 30 min (Fig. 6, panel A). This effect
of HGF on the regulatory subunit of the PI3-K was
concentration-dependent (Fig. 6, panel B) and was exclu-
sively linked to HGF stimulation as maximal concentrations
of CCK and EGF did not promote any effect in the
regulatory subunit associated with the anti-phosphotyrosine
immunoprecipitates (Fig. 6, panel C).hosphotyrosine immunoprecipitates. Rat pancreatic acini were treated for
. Lysates were immunoprecipitated with anti-phosphotyrosine PY20 mAb.
ubunit antibody. Panel A, time course of association of p85 with tyrosine
time-dependent effect. Lower panel: quantification of bands was performed
four independent experiments. Panel B, HGF concentration-dependence of
and the results shown are representative of four independent experiments.
ated with HGF (1 nM, 2.5 min), or CCK (10 nM, 2.5 min) or EGF (10 nM,
Fig. 7. Time-dependence of HGF stimulation of Ser473Akt phosphorylation. Rat pancreatic acini were treated for indicated times with no addition or with
indicated HGF concentration and lysed. Cell lysates (10 Ag) were analyzed by SDS-PAGE and Western blotting using a phospho-specific (Ser473) anti-Akt or
anti-Akt antibodies. Panel A, HGF stimulation leads to phosphorylation of Ser473 of Akt. Upper panel shows a representative result from one experiment in
which pancreatic acini were treated with HGF (1 nM) assessed at the indicated times. Lower panel, quantification of bands was performed by scanning
densitometry. Values shown at the bottom graph are meanF S.E. of four independent experiments. Panel B, HGF concentration-dependence of Akt
phosphorylation. Acini were incubated 2.5 min with indicated HGF concentrations and the results shown are representative of three independent experiments.
Panel C, effect of HGF, CCK-8 or EGF on Akt phosphorylation. Acini were incubated with HGF (1 nM, 2.5 min), or CCK (10 nM, 2.5 min) or EGF (10 nM, 1
min) and the results shown are representative of three independent experiments.
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rapid increase in the phosphorylation of Serine 473 of the
protein serine/threonine kinase B or Akt (Fig. 7, panel A).
This effect was time-dependent (Fig. 7, panel A) and
concentration-dependent (Fig. 7, panel B) and was specific
for HGF treatment, as CCK or EGF did not cause any effectFig. 8. HGF stimulation leads to tyrosine phosphorylation of tyrosine phosphatase
or with indicated HGF concentration and lysed. Lysates were immunoprecipitated
analyzed by Western blotting with anti-PTP1D antibody. Panel A, time course o
representative experiment showing a time-dependent effect of HGF. Lower panel
shown at the bottom graph are meanF S.E. of four independent experimen
phosphorylation. Acini were incubated 2.5 min with the indicated HGF conc
experiments. Panel C, effect of HGF, CCK-8 or EGF on PTP1D tyrosine phospho
2.5 min) or EGF (10 nM, 1 min) and the results shown are representative of fouon the phosphorylation of Akt (Fig. 7, panel C). In these
conditions, the level of Akt protein remained unaffected
(Fig. 7, panel A).
The tyrosine phosphatase PTPD1 was itself tyrosine
phosphorylated in pancreatic acini following HGF treatment
in a time- and dose-dependent manner (Fig. 8). The increasePTP1D. Rat pancreatic acini were treated for indicated time with no addition
with anti-phosphotyrosine PY20 mAb. Resulting immunocomplexes were
f HGF stimulation of PTP1D tyrosine phosphorylation. Upper panel is a
, quantification of bands was performed by scanning densitometry. Values
ts. Panel B, HGF concentration-dependence effect on PTP1D tyrosine
entrations and the results shown are representative of four independent
rylation. Acini were incubated with HGF (1 nM, 2.5 min), or CCK (10 nM,
r independent experiments.
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within 1 min) as seen in Fig. 8 (panel A). Detectable
phosphorylation was seen with 0.06 and 0.3 nM HGF and
caused a maximal 4-fold increase (Fig. 8, panel B).This
effect was exclusive to HGF as maximal concentrations of
CCK and EGF did not cause any effect on its tyrosine
phosphorylation levels (Fig. 8, panel C).4. Discussion
The expression of c-met has been predominately found in
cells of epithelial origin [2]. C-met expression in rat pan-
creas was originally described by RT-PCR and follows the
rate of pancreatic cell proliferation with the maximal match-
ing a period of fetal rapid proliferation of the pancreatic
gland [6]. The study was performed using total RNA
isolated not only from exocrine but also endocrine pancreas.
In the present study, we have also demonstrated the presence
of c-met (Met) in adult rat pancreas by immunohistochem-
istry. This agrees with previous results in the literature. Anti-
c-met immunoreactivity has been demonstrated in fetal [23]
and adult [13] pancreatic epithelial cells. Moreover, we have
isolated rat pancreatic acinar cells and confirmed the ex-
pression of c-met by immunoprecipitation followed by
Western blot with a specific antibody.
C-met is a prototypic member of a small subfamily of
receptor tyrosine kinase (RTKs) that can induce different
physiological responses in several cell types. Activation of
signal transduction pathways in response to HGF stimula-
tion is mediated in part by autophosphorylation of specific
tyrosine residues within the intracellular region of c-met [2].
We have demonstrated in this study that HGF treatment of
rat pancreatic acinar cells promoted the tyrosine phosphor-
ylation of c-met in a time- and concentration-dependent
manner. Transactivation of growth factor receptors such as
EGF has been described in response to stimulation of a
different receptor in the same cells [24]. Our results show
that tyrosine phosphorylation of c-met was only achieved
after HGF stimulation but not after another growth factor,
EGF or the main physiological regulator of these cells,
CCK. These results show that there is no transactivation of
c-met promoted by CCKA receptor or EGF receptor activa-
tion in rat pancreatic acini. Additionally, our results support
the idea that c-met mediates intracellular signaling in
pancreatic acinar cells at least in part by autophosphoryla-
tion of specific tyrosine residues. It is known that tyrosine
phosphorylation of Tyr1234 and Tyr1235, located within the
kinase domain, activates the intrinsic kinase activity of c-
met receptor, while phosphorylation of Tyr1349 and Tyr1356
in the C-terminus activates a multisubstrate docking site that
mediates the binding of several adapter proteins. One of
these known adapter proteins is Grb2, which in turn recruits
the signal transducing protein SOS to activated Met to
induce Ras-ERK1/2 signaling [2]. In this regard, results
from this study show that HGF stimulation of rat pancreaticacinar cells rapidly leads to phosphorylation and in turn
activation of p44 and p42 ERK1/2. HGF is able to induce
this intracellular signal cascade in a comparable degree to
that caused by the pancreatic secretagogue CCK. However,
HGF stimulation of ERK1/2 is stronger than the stimulation
caused by another growth factor, EGF.
PI3-K, a heterodimer with an 85-kDa regulatory subunit
and a 110-kDa catalytic subunit, is activated by a variety of
stimuli and is involved in the triggering of many different
cell activities. Our results demonstrated that the amount of
the p85 regulatory subunit of the PI3-K is clearly increased
in the anti-phosphotyrosine immunoprecipitates following
HGF stimulation. This data can be explained at least by
three different hypotheses. (i) The p85 regulatory subunit
can be phosphorylated at tyrosine residues after HGF
stimulation [25]. In this regard, there are discrepancies in
the literature regarding the tyrosine phosphorylation of p85
following HGF stimulation [26,27]. (ii) A second explana-
tion implies that the p85 regulatory subunit of PI3-K can be
associated directly with c-met via a phosphotyrosine bind-
ing domain (PTB) located within the multisubstrate binding
site originated after HGF stimulation at the C-terminus [28].
According to this explanation, in our study, HGF stimu-
lation in pancreatic acinar cells promotes that autophos-
phorylated c-met is immunoprecipitated with the anti-
phosphotyrosine antibody, as demonstrated in Fig. 3, and
so is the p85 bound to it via its PTB domain. (iii) A third
plausible explanation involves Gab1 (Grb2-associated bind-
ing protein-1), which is an adapter protein recruited by Grb2
after HGF stimulation. Gab1 is a protein containing a N-
terminal pleckstrin homology (PH) domain that binds the
membrane lipid phosphatidylinositol 3,4,5-trisphosphate
(PIP3), product of the PI3-K. Following HGF treatment
Gab1 is tyrosine phosphorylated which induce its direct
association with several transducers including PI3-K [29].
Then, in our model, following HGF treatment PI3-K would
co-immunoprecipitate with HGF-induced tyrosine phos-
phorylated proteins including Gab1.
Independently of how the p85 subunit becomes a signal-
ing molecule, our results clearly show that PI3-K is involved
in HGF-induced intracellular signaling in rat pancreatic
acini. It is well demonstrated that downstream of PI3-K,
Akt (or PKB) is a key molecule. Activation of Akt is
dependent on the sequential phosphorylation of the mole-
cule at two specific sites, Thr 308 and Ser 473. Full
activation is achieved when Ser 476 is phosphorylated. In
our study, we have found that HGF activates intracellular
signaling leading to Akt phosphorylation at the Ser 473.
One of the SH2-containing proteins recruited by c-met is
the tyrosine phosphatase PTP1D (also called SHPTP2,
PTP2C, SHPTP3, Syp, or SHP2) and upon c-met activation,
PTP1D becomes phosphorylated on tyrosines and serves as
an adapter protein (reviewed by Furge et al. [2]). Moreover,
downstream from c-met receptor, through the association of
PTP1D with Gab1 [2,30] previous studies have identified
this phosphatase as both positive modulator of ERK1/2
I.M. Aparicio et al. / Biochimica et Biophysica Acta 1643 (2003) 37–46 45activity and selective activator of PI3-Kinase [30]. In our
study in rat pancreatic acini, we have found that c-met
activation, but not EGF-receptor activation, selectively leads
to tyrosine phosphorylation of the protein phosphatase
PTP1D in a time- and dose-regulated manner.
Our data demonstrated that HGF/c-met signaling is not
involved in one of the main pancreatic acinar cell function,
secretion of digestive enzymes. The biological role of HGF
in normal exocrine pancreas is unclear. Previous data
suggested that, according to their expression levels, HGF
and its receptor could be implicated in normal pancreas
development and maturation because their period of maxi-
mal expression matches the period of rapid proliferation of
the endocrine and exocrine pancreas [6]. In pancreatic
AR42J cells derived from rat pancreatic acinar tumors,
HGF induced differentiation via ERK1/2 pathway [31]. It
is interesting to note that in our study the comparison of
those intracellular signal cascades activated by either growth
factors HGF and EGF or the pancreatic secretagogue CCK,
points at HGF as a stimulus comparable to CCK in
activating the ERK1/2 cascade in rat pancreatic acini.
Additionally, our study reveals that HGF is a more potent
stimulus for pancreatic acinar cells than EGF, which has
been previously used as the typical growth factor in these
cells [32,33]. It is well known that PI3-K and Akt signaling
molecules are involved in several biological functions,
including cell survival and proliferation. These biological
functions have been demonstrated for HGF only in fetal and
early phases of postnatal pancreas development [6]. In our
study, HGF was an exclusive stimulus in rat pancreatic
acinar cells regulating the PI3-K/Akt cascade because it was
not regulated by CCK or EGF. Therefore, the suggested role
in pancreatic acinar in cell survival and proliferation during
development [6] could be potentially extended to adult age,
considering the demonstrated ability of HGF to induce PI3-
K/Akt and possibly other involved pathways. Further work
is necessary to demonstrate this suggested role of HGF in
pancreatic acinar cells.
In summary, the data presented in this study demonstrate
the expression of the c-met in pancreatic acinar cells and
describe a variety of intracellular signaling pathways acti-
vated by HGF in vivo. Our results demonstrate that HGF
intracellular signaling in pancreatic acinar cells involves
autophosphorylation of c-met, ERK1/2 activation, tyrosine
phosphorylation of the phosphatase PTP1D, modulation of
the p85 regulatory subunit of PI3-K and subsequent activa-
tion of its downstream target Akt. Comparing the degree of
activation of the different signaling pathways, our results
reveal that HGF is a stronger stimulus than EGF in pancre-
atic acini and its level of stimulation is comparable to the
degree of stimulation described for CCK on ERK1/2 acti-
vation. The role of HGF has already been extensively
investigated in pancreatic carcinoma cells. However, there
is no data in the literature to date regarding the function and
signaling pathways of HGF in normal pancreatic acinar
cells. Our study provides novel insight into the signalingrequirements coupled to c-met to promote HGF’s role in
vivo in normal pancreatic acinar cells.Acknowledgements
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